- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 29.07. | Thermo Fisher Scientific Introduces IntelliStack Incubator and Shakers | ||
| 29.07. | Boehringer Ingelheim Acquires Nerio Therapeutics | ||
| 29.07. | Cytiva Introduces Supor Prime Sterilizing Grade Filters | ||
| 29.07. | GSK, Flagship Pioneering Partner to Discover & Develop Medicines and Vaccines | ||
| 29.07. | Waters Launches New Rapid Screening-DSC | ||
| 29.07. | Hummingbird Bioscience Appoints New CMO and COO | ||
| 29.07. | FDA Approves Sun Pharma's LEQSELVI to Treat Severe Alopecia Areata | ||
| 29.07. | Roche Completes $2.7B Acquisition of Carmot Therapeutics | ||
| 29.07. | Compounded Injectable Semaglutide Dosing Errors Result in Reports of Adverse Events | ||
| 29.07. | BioVaxys Partners to Develop DPX-Based Therapy for Food Allergies | ||
| 26.07. | Piramal Pharma Revenue Increases 12% YoY in Q1 | ||
| 26.07. | Cellectis' UCART22 Granted ODD and RPDD Status by FDA | ||
| 25.07. | Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN | ||
| 25.07. | Emmes, Miimansa AI Partner on Generative AI in Clinical Research | ||
| 25.07. | Stuart Therapeutics Taps Dr. Lukas Scheibler as Chief Science & Technology Officer | ||
| 25.07. | Almac Completes FDA Inspection at Charnwood, UK Facilities | ||
| 25.07. | Capra Biosciences Receives $7.5M Project Agreement | ||
| 25.07. | Catalyst Grants Kye Exclusive Canadian Commercial Rights to AGAMREE | ||
| 25.07. | Xavo Welcomes Plexium as Its Latest Client | ||
| 25.07. | Neuraxpharm to Utilize Veeva Quality Applications | ||
| 24.07. | RxSource to Relocate to Larger Facility in West Deptford, NJ | ||
| 24.07. | Carbogen Amcis Completes FDA Inspections at Two Manufacturing Sites | ||
| 24.07. | Johnson & Johnson Strengthens Position in Italy with €580M Investment | ||
| 24.07. | Agilent to Acquire North American CDMO BioVectra | ||
| 24.07. | De Motu Cordis Expands DPI Partnership with Catalent |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
